- JP-listed companies
- Cuorips Inc.
- Cash flow
Cuorips Inc. (4894) Cash flow
Market cap
¥35.3B
P/E ratio
-25.8x
Qualips develops regenerative medicine treatments using human iPS cells, specializing in cardiac muscle cell sheets for severe heart failure patients.
| 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 74 | 93 | 79 | 70 | 77 | 84 |
| Cash from operations | -283 | -221 | -402 | -451 | -813 | -1,060 |
| Capital expenditures | -668 | -29 | -5 | -24 | -80 | -43 |
| Cash from investing | -670 | -28 | -9 | -35 | -120 | -35 |
| Repurchases of common stock | - | - | - | -0 | -1 | -0 |
| Cash from financing | 3,767 | 49 | 11 | 3,125 | 145 | 204 |